Tarsus Pharmaceuticals Financial Overview
Tarsus Pharmaceuticals's market cap is currently $3.49B. The company's EPS TTM is $-0.3; its P/E ratio is ―; Tarsus Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
